JP2012510518A - 体液貯留障害を処置するための方法および組成物 - Google Patents
体液貯留障害を処置するための方法および組成物 Download PDFInfo
- Publication number
- JP2012510518A JP2012510518A JP2011539635A JP2011539635A JP2012510518A JP 2012510518 A JP2012510518 A JP 2012510518A JP 2011539635 A JP2011539635 A JP 2011539635A JP 2011539635 A JP2011539635 A JP 2011539635A JP 2012510518 A JP2012510518 A JP 2012510518A
- Authority
- JP
- Japan
- Prior art keywords
- xaa
- ile
- ala
- leu
- absent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
- A61K35/10—Peat; Amber; Turf; Humus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11926208P | 2008-12-02 | 2008-12-02 | |
| US61/119,262 | 2008-12-02 | ||
| PCT/US2009/066227 WO2010065524A2 (en) | 2008-12-02 | 2009-12-01 | Methods and compositions for the treatment of fluid retention disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2012510518A true JP2012510518A (ja) | 2012-05-10 |
Family
ID=42233813
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011539635A Withdrawn JP2012510518A (ja) | 2008-12-02 | 2009-12-01 | 体液貯留障害を処置するための方法および組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20120028897A1 (de) |
| EP (1) | EP2370087A4 (de) |
| JP (1) | JP2012510518A (de) |
| WO (1) | WO2010065524A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9303066B2 (en) | 2011-05-11 | 2016-04-05 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
| MX347354B (es) | 2011-08-17 | 2017-04-24 | Ironwood Pharmaceuticals Inc | Tratamientos para trastornos gastrointestinales. |
| GB2521563B (en) * | 2012-10-03 | 2020-08-19 | Waters Technologies Corp | Chromatographic separation device with integral memory |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2905585C (en) * | 2001-03-29 | 2020-02-18 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists for the treatment and/or prevention of cancer or polyps |
| BRPI0511127A (pt) * | 2004-05-14 | 2007-11-27 | Univ North Carolina | prouroguanilina e análogos sintéticos ou produtos da clivagem proteolìtica dela derivados, como agentes terapêuticos e de diagnósticos para doenças que envolvem a homeostasia de sal e/ou de lìquidos |
| WO2011057272A1 (en) * | 2009-11-09 | 2011-05-12 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
-
2009
- 2009-12-01 EP EP09830969.3A patent/EP2370087A4/de not_active Withdrawn
- 2009-12-01 JP JP2011539635A patent/JP2012510518A/ja not_active Withdrawn
- 2009-12-01 US US13/132,262 patent/US20120028897A1/en not_active Abandoned
- 2009-12-01 WO PCT/US2009/066227 patent/WO2010065524A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| US20120028897A1 (en) | 2012-02-02 |
| WO2010065524A3 (en) | 2010-09-02 |
| WO2010065524A2 (en) | 2010-06-10 |
| EP2370087A2 (de) | 2011-10-05 |
| EP2370087A4 (de) | 2013-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101389648B (zh) | 肽胃泌酸调节素衍生物 | |
| ES2901477T3 (es) | Nuevos análogos de urocortina-2 modificados con ácidos grasos para el tratamiento de la diabetes y la enfermedad renal crónica | |
| US12600749B2 (en) | Compstatin analogues and their medical uses | |
| TWI541020B (zh) | 生物活性胜肽 | |
| ES2763329T3 (es) | Análogo de glucagón acilado | |
| CN102197049B (zh) | 胰岛淀粉样多肽衍生物 | |
| JP2020505352A (ja) | インターロイキン−23受容体のペプチド阻害剤および炎症性疾患を治療するためのそれらの使用 | |
| Ung et al. | Tripeptide motifs in biology: targets for peptidomimetic design | |
| JP7711044B2 (ja) | コンプスタチン類似体及びその医学的使用 | |
| TW202317604A (zh) | 用於治療遺傳性血鐵沉積症之鐵調素模擬物 | |
| KR20230120134A (ko) | 폴리펩티드 및 이의 용도 | |
| US20230287051A1 (en) | Inhibitors of complement factor c3 and their medical uses | |
| RU2603286C2 (ru) | Циклические пептиды с антинеопластической и антиангионенной активностью | |
| JP2021176875A (ja) | ポリエチレングリコール(peg)−インターロイキン11(il−11)コンジュゲートを生成するための反応中間体、および、peg−il−11コンジュゲートを精製する方法 | |
| JP2012510518A (ja) | 体液貯留障害を処置するための方法および組成物 | |
| TW201734035A (zh) | 胜肽類似物 | |
| JP2017501967A (ja) | 新規なペプチド組成物 | |
| TW201625678A (zh) | 合成肽 | |
| HK40092906A (zh) | 补体因子c3的抑制剂及其医学用途 | |
| EA049126B1 (ru) | Аналоги компстатина и пути их медицинского применения |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20121130 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20130814 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20130814 |